Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(43%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_2
1
14%
Ph phase_3
3
43%
Ph phase_4
3
43%

Phase Distribution

0

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
3(42.9%)
Phase 4Post-market surveillance
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Active, not recruiting2
unknown1
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (14.3%)
Phase 33 (42.9%)
Phase 43 (42.9%)

Trials by Status

completed229%
unknown114%
withdrawn114%
recruiting114%
active_not_recruiting229%

Recent Activity

3 active trials
Showing 5 of 7
active_not_recruitingphase_4

Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

NCT04467983
unknownphase_3

Clinical Controlled Study on the Efficacy of Denosumab in Treating Osteoporosis in the Domestic Population and Its Impact on Sarcopenia-related Outcomes

NCT06154707
recruitingphase_3

The DENOCHARCOT Trial

NCT04547348
active_not_recruitingphase_3

Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer

NCT03324932
completedphase_4

Denosumab vs Zoledronate After Vertebroplasty

NCT05598606
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT04467983Phase 4

Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

Active Not Recruiting
NCT06154707Phase 3

Clinical Controlled Study on the Efficacy of Denosumab in Treating Osteoporosis in the Domestic Population and Its Impact on Sarcopenia-related Outcomes

Unknown
NCT04547348Phase 3

The DENOCHARCOT Trial

Recruiting
NCT03324932Phase 3

Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer

Active Not Recruiting
NCT05598606Phase 4

Denosumab vs Zoledronate After Vertebroplasty

Completed
NCT04231682Phase 2

A Study to Evaluate Efficacy and Safety of Denosumab for Prevention and Treatment of Osteoporosis in 1st Time Liver Transplant Recipients.

Withdrawn
NCT01750086Phase 4

Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7